ArticleInflammatory bowel diseases2021

Corrigendum to: Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.